Burney CO Regeneron Pharmaceuticals, Inc. Transaction History

Burney CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$478.3 - $607.98 $737,538 - $937,505	-1,542 Closed	0 $0
Q3 2020 Dec 14, 2020	SELL	$544.75 - $658.21 $56,654 - $68,453	-104 Reduced 6.32%	1,542 $863,000
Q2 2020 Aug 13, 2020	SELL	$493.32 - $643.92 $234,327 - $305,862	-475 Reduced 22.4%	1,646 $1.03 Million
Q1 2020 May 13, 2020	BUY	$336.18 - $494.43 $55,805 - $82,075	166 Added 8.49%	2,121 $1.04 Million
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $535,924 - $736,077	1,955 New	1,955 $734,000

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

Stay updated on Burney CO with notifications on news.